DE69739120D1 - Staphylococcus aureus antigen - Google Patents

Staphylococcus aureus antigen

Info

Publication number
DE69739120D1
DE69739120D1 DE69739120T DE69739120T DE69739120D1 DE 69739120 D1 DE69739120 D1 DE 69739120D1 DE 69739120 T DE69739120 T DE 69739120T DE 69739120 T DE69739120 T DE 69739120T DE 69739120 D1 DE69739120 D1 DE 69739120D1
Authority
DE
Germany
Prior art keywords
antigen
aureus
type
strains
staphylococcus aureus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69739120T
Other languages
English (en)
Inventor
Ali Ibrahim Fattom
Atulkumar Induprasad Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nabi Biopharmaceuticals Inc
Original Assignee
Nabi Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nabi Biopharmaceuticals Inc filed Critical Nabi Biopharmaceuticals Inc
Application granted granted Critical
Publication of DE69739120D1 publication Critical patent/DE69739120D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/964—Chemistry: molecular biology and microbiology including enzyme-ligand conjugate production, e.g. reducing rate of nonproductive linkage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Dental Preparations (AREA)
DE69739120T 1996-09-11 1997-09-11 Staphylococcus aureus antigen Expired - Lifetime DE69739120D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/712,438 US5770208A (en) 1996-09-11 1996-09-11 Staphylococcus aureus B-linked hexosamine antigen
PCT/US1997/016045 WO1998010788A1 (en) 1996-09-11 1997-09-11 Staphylococcus aureus antigen

Publications (1)

Publication Number Publication Date
DE69739120D1 true DE69739120D1 (en) 2009-01-02

Family

ID=24862114

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69739120T Expired - Lifetime DE69739120D1 (en) 1996-09-11 1997-09-11 Staphylococcus aureus antigen

Country Status (12)

Country Link
US (2) US5770208A (de)
EP (1) EP0925073B1 (de)
JP (2) JP4282765B2 (de)
AT (1) ATE414532T1 (de)
AU (1) AU725181B2 (de)
CA (1) CA2265498C (de)
DE (1) DE69739120D1 (de)
DK (1) DK0925073T3 (de)
ES (1) ES2317655T3 (de)
NZ (1) NZ334828A (de)
PT (1) PT925073E (de)
WO (1) WO1998010788A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7279162B1 (en) 1990-10-22 2007-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
US6933366B2 (en) * 1996-12-27 2005-08-23 Tripep Ab Specificity exchangers that redirect antibodies to bacterial adhesion receptors
US6040137A (en) * 1995-04-27 2000-03-21 Tripep Ab Antigen/antibody specification exchanger
US6660842B1 (en) 1994-04-28 2003-12-09 Tripep Ab Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
US6294177B1 (en) 1996-09-11 2001-09-25 Nabi Staphylococcus aureus antigen-containing whole cell vaccine
US5770208A (en) * 1996-09-11 1998-06-23 Nabi Staphylococcus aureus B-linked hexosamine antigen
US6610293B1 (en) * 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US7250494B2 (en) * 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
US8142780B2 (en) * 1998-08-20 2012-03-27 Strox Biopharmaceuticals, Llc Anti-bacterial antibodies
US6322788B1 (en) 1998-08-20 2001-11-27 Stanley Arthur Kim Anti-bacterial antibodies and methods of use
US6824997B1 (en) 1998-09-18 2004-11-30 Binax, Inc. Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
US9134303B1 (en) 1998-08-25 2015-09-15 Alere Scarborough, Inc. ICT immunoassay for Legionella pneumophila serogroup 1 antigen employing affinity purified antibodies thereto
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US7030101B2 (en) 1998-09-14 2006-04-18 Nabi Biopharmaceuticals Compositions of β-glucans and specific antibodies
ES2321892T3 (es) * 1998-09-14 2009-06-12 Nabi Biopharmaceuticals Composiciones de beta-glucanos e inmunoglobulinas especificas.
US6936258B1 (en) * 1999-03-19 2005-08-30 Nabi Biopharmaceuticals Staphylococcus antigen and vaccine
US20030113350A1 (en) * 2001-09-19 2003-06-19 Fattom Ali I. Glycoconjugate vaccines for use in immune-compromised populations
DE60230670D1 (de) * 2001-12-11 2009-02-12 Merck & Co Inc Staphylococcus aureus exopolysaccharid und verfahren
US6984381B2 (en) * 2002-07-05 2006-01-10 The United States Of America As Represented By The Secretary Of Agriculture Vaccine for the prevention of bacterial infection of the bovine mammary gland
WO2004050846A2 (en) * 2002-12-02 2004-06-17 Biosynexus Incorporated Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines
EP1594898A2 (de) 2003-02-06 2005-11-16 Tripep AB Glycosylierte spezifitätaustauscher
US7335359B2 (en) 2003-02-06 2008-02-26 Tripep Ab Glycosylated specificity exchangers
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US8170803B2 (en) 2004-07-13 2012-05-01 Dexcom, Inc. Transcutaneous analyte sensor
US20060134141A1 (en) * 2004-12-14 2006-06-22 Nabi Biopharmaceuticals Glycoconjugate vaccines containing peptidoglycan
MX2007008358A (es) * 2005-01-10 2007-09-06 Nabi Biopharmaceuticals Metodo para tratar la infeccion con staphylococcus aureus.
US20060228368A1 (en) * 2005-04-07 2006-10-12 Nabi Biopharmaceuticals Method of protecting against staphylococcal infection
JP5096326B2 (ja) 2005-06-13 2012-12-12 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ブドウ球菌感染を治療および予防するためのＰａｎｔｏｎ−Ｖａｌｅｎｔｉｎｅロイコシジンの使用
ES2961309T3 (es) † 2006-02-22 2024-03-11 Dexcom Inc Sensor de analito
TW200744632A (en) * 2006-06-12 2007-12-16 Nabi Biopharmaceuticals Use of alpha-toxin for treating and preventing staphylococcus infections
US9119582B2 (en) 2006-06-30 2015-09-01 Abbott Diabetes Care, Inc. Integrated analyte sensor and infusion device and methods therefor
US20090092631A1 (en) * 2007-03-26 2009-04-09 Tripep Ab Glycosylated specificity exchangers that induce an antibody dependent cellular cytotoxicity (adcc) response
EP2193192A1 (de) * 2007-09-25 2010-06-09 Check Light Ltd Zusammensetzungen und verfahren zur lagerung von bakteriensuspensionen
CN102089005A (zh) * 2008-05-12 2011-06-08 斯特罗克斯生物制药有限责任公司 金黄色葡萄球菌特异性抗体制剂
JP5830009B2 (ja) 2009-04-14 2015-12-09 ノバルティス アーゲー Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓに対して免疫化するための組成物
US8974799B2 (en) 2009-09-30 2015-03-10 Novartis Ag Conjugation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides
DK2493498T3 (en) 2009-10-30 2017-05-08 Glaxosmithkline Biologicals Sa Purification of Staphylococcus aureus type 5 and type 8 capsule saccharides
GB0919690D0 (en) 2009-11-10 2009-12-23 Guy S And St Thomas S Nhs Foun compositions for immunising against staphylococcus aureus
CN102120761B (zh) * 2010-12-24 2013-02-06 新疆维吾尔自治区畜牧科学院兽医研究所 一种无荚膜型金黄色葡萄球菌胞外多糖-蛋白质偶联物的制备方法
UA105278C2 (ru) 2012-09-06 2014-04-25 Інститут Біології Клітини Нан України Способ получения каталитически активных антител (абзимов) с сиалидазной активностью
WO2015187779A1 (en) 2014-06-03 2015-12-10 Xbiotech, Inc. Compositions and methods for treating and preventing staphylococcus aureus infections
CN105372427A (zh) * 2015-10-22 2016-03-02 南昌大学 一种基于KMnF4纳米探针的NMR食源性致病菌快速检测方法
FR3092292A1 (fr) 2019-02-06 2020-08-07 Cresco Système d'éclairage pour un véhicule ou son conducteur.
CN115105588B (zh) * 2021-03-23 2024-03-15 成都威斯克生物医药有限公司 一种金黄色葡萄球菌疫苗的生产方法及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399229A (en) * 1980-04-14 1983-08-16 Immutron, Inc. Rapid radioimmunoassay product and method of making and using same
DE3345864A1 (de) * 1983-12-19 1985-06-27 Egbert Frh. von 8000 München Malsen-Ponickau Impfstoff und verfahren zu seiner herstellung
IN164864B (de) * 1985-05-13 1989-06-24 Commw Scient Ind Res Org
FR2619122B1 (fr) * 1987-08-03 1990-03-09 Pasteur Institut Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede
US5472846A (en) * 1994-08-18 1995-12-05 Rotman; M. Boris Test kit and method for amplification and detection of antigen cells
US5792617A (en) * 1994-08-18 1998-08-11 Rotman; M. Boris Cell proliferation-based amplified detection of analytes
US5770208A (en) * 1996-09-11 1998-06-23 Nabi Staphylococcus aureus B-linked hexosamine antigen

Also Published As

Publication number Publication date
JP4282765B2 (ja) 2009-06-24
NZ334828A (en) 2000-10-27
US5770208A (en) 1998-06-23
WO1998010788A1 (en) 1998-03-19
US6194161B1 (en) 2001-02-27
PT925073E (pt) 2009-01-22
JP2001507566A (ja) 2001-06-12
ES2317655T3 (es) 2009-04-16
DK0925073T3 (da) 2009-01-19
EP0925073A1 (de) 1999-06-30
CA2265498A1 (en) 1998-03-19
AU4340597A (en) 1998-04-02
EP0925073A4 (de) 2004-12-08
JP2009007355A (ja) 2009-01-15
ATE414532T1 (de) 2008-12-15
AU725181B2 (en) 2000-10-05
CA2265498C (en) 2011-08-02
EP0925073B1 (de) 2008-11-19

Similar Documents

Publication Publication Date Title
DE69739120D1 (en) Staphylococcus aureus antigen
DK1178824T3 (da) Staphylococcus aureus-antigenholdig helcellevaccine
MXPA01009476A (es) Antigeno de staphylococcus y vacuna.
CA2195556A1 (en) Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
IL96946A0 (en) Boronic acid derivatives and diagnostic methods and kits incorporating the same
AU583827B2 (en) Platinum co-ordination compounds
HK1033582A1 (en) Antibodies to death receptor 4 (dr4) and uses thereof
AU520027B2 (en) Solenoid operated bolt and buffer
EP0037110A3 (en) Method for enzyme immunoassay and peptide-enzyme conjugate, its lyophilizate, antibody and kit therefor
DE3874059D1 (de) Klappenventile.
AU6550294A (en) Genetically engineered enzymes and their conjugates for diagnostic assays
AU7336400A (en) Diagnostic assay for type 2 heparin-induced thrombocytopenia
DE69004550D1 (de) Schmierfett für homokinetische Kupplung.
CA2070647A1 (en) Use of an anticoagulant as a diagnostic agent
CA2008304A1 (en) Assay for bone alkaline phosphatase
DE68908896D1 (de) Flanschkupplung für ventile.
AU5043285A (en) Pipeline inspection
AU4632689A (en) Structural and enzymatic assays on glycocompounds, their use in the diagnosis of cancer, kits for use in the assays and a device for taking a sample of secretion via a body opening
NZ211850A (en) Enzyme immunoassay, methods and kits
AU1322388A (en) Pipeline conditioning
CA2027977A1 (en) Arylsulfatase
AU1117188A (en) 14,15-substituted lanosterols and their use as hypocholesterolemic agents
SU1113918A1 (ru) Антигельминтное средство
GB9606425D0 (en) Improvements in and relating to the production of antibodies and test kits incorporating antibodies
AU6043894A (en) Antibiotic assay and kits for the use thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition